Company / Shares Outstanding
Xenon Pharmaceuticals Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
79.3M
FY2025
5-year range
43.6M / 79.3M
FY2021-FY2025
Trend
+1.7%
vs FY2024
Sector context
#119 of 212
Health Care
What the data says
At 79253751.00, Xenon Pharmaceuticals Inc.'s shares outstanding ranks #94 of 212 in the Health Care sector. Shares Outstanding has increased for 9 consecutive years, from 14385336.00 in FY2016 to 79253751.00 in FY2025.
Based on SEC 10-K filings.
79253751.00 in FY2025 with a 5-year CAGR of +18.1%.
Increased from 66889005.00 to 79253751.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +9.4%
- 5-Year CAGR
- +18.1%
- 10-Year CAGR
- -
Sector benchmark
#94 of 212 in Health CareTop 44% of 212This company 79.3M Sector average 306.7M
▼
-74.2% below sector average
Key checks
Key Insights
- Xenon Pharmaceuticals Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 1.7% year-over-year.
- Ranks #119 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 79.3M | +1.7% |
| FY2024 | 77.9M | +16.5% |
| FY2023 | 66.9M | +10.5% |
| FY2022 | 60.5M | +38.8% |
| FY2021 | 43.6M | +26.3% |
| FY2020 | 34.5M | +33.2% |
| FY2019 | 25.9M | +44.1% |
| FY2018 | 18.0M | +0.4% |
| FY2017 | 17.9M | +24.6% |
| FY2016 | 14.4M | +1.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026